Skip to main content
Equibles
BIOF logo

BIOF · Blue Biofuels, Inc. · Metrics

Track BIOF — free

Use BIOF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BIOF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.11 0.00 (-0.47%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, there is substantial doubt about the Company's ability to continue as a going concern based upon recurring operating losses and its need to obtain additional financing to sustain operations.”
View the 10-Q filed Aug 10, 2026
Market Cap
$35.01M
Shares
324.17M
Volume · Oct 2 97.09K Avg daily vol (3M) 161.63K

BIOF metrics

52 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.11
Market cap
$35.01M

Price action

20 metrics
Price change (1W)
+2.9%
Price change (30D)
+1.0%
Price change (3M)
-11.7%
Price change (6M)
-24.8%
Price change (YTD)
-44.2%
Price change (1Y)
-42.7%
Trailing year
Price change (5Y)
-63.4%
52-week high
$0.19
52-week low
$0.09
Change from 52-week high
-44.2%
Change from 52-week low
+14.6%
Annualized volatility
54.3%
Annualized volatility (3M)
61.8%
Beta
0.3
RSI (14D)
51.8
Price vs SMA 50
+1.4%
Price vs SMA 200
-24.9%
Avg volume (3M)
161,631
Relative volume
0.6
Average dollar volume
$17,007

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
324.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-2,961.1%
Trailing 12 months
Net margin
1,675.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$3.51M
Net income (TTM)
−$3.12M
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.01

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-236.5%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$3.40M
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$22,040
Total assets
$1.32M
Total debt
$2.42M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.23M
Capital expenditures (TTM)
—
R&D (TTM)
$2.30M
SG&A (TTM)
—
Stock compensation (TTM)
$982,508
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
39 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$141,000
Insider-sentiment score
36 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1549145 CUSIP 09530Q102 Visit website